IL156933A0 - Stabilized brivudine topical formulations containing metal oxide pigments - Google Patents

Stabilized brivudine topical formulations containing metal oxide pigments

Info

Publication number: IL156933A0
Authority: IL; Israel
Prior art keywords: stabilized; metal oxide; containing metal; formulations containing; topical formulations
Prior art date: 2001-01-17

Application number

IL15693302A

Other languages

English (en)

Original Assignee

Berlin Chemie Ag

Menarini Ricerche Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-17

Filing date

2002-01-10

Publication date

2004-02-08

2002-01-10 Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag

2004-02-08 Publication of IL156933A0 publication Critical patent/IL156933A0/xx

Links

229960001169 brivudine Drugs 0.000 title 1
ODZBBRURCPAEIQ-PIXDULNESA-N helpin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(\C=C\Br)=C1 ODZBBRURCPAEIQ-PIXDULNESA-N 0.000 title 1
229910044991 metal oxide Inorganic materials 0.000 title 1
150000004706 metal oxides Chemical class 0.000 title 1
239000000049 pigment Substances 0.000 title 1
239000012049 topical pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Virology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Biotechnology (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL15693302A 2001-01-17 2002-01-10 Stabilized brivudine topical formulations containing metal oxide pigments IL156933A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01100968		2001-01-17
PCT/EP2002/000163 WO2002056913A2 (en)	2001-01-17	2002-01-10	Stabilized brivudine topical formulations containing metal oxide pigments

Publications (1)

Publication Number	Publication Date
IL156933A0 true IL156933A0 (en)	2004-02-08

Family

ID=8176229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15693302A IL156933A0 (en)	2001-01-17	2002-01-10	Stabilized brivudine topical formulations containing metal oxide pigments

Country Status (28)

Country	Link
US (1)	US20040087602A1 (cs)
EP (1)	EP1365772A2 (cs)
JP (1)	JP2004519460A (cs)
KR (1)	KR20030070109A (cs)
CN (1)	CN1236777C (cs)
AR (1)	AR035530A1 (cs)
AU (1)	AU2002244642B2 (cs)
BG (1)	BG107988A (cs)
BR (1)	BR0206478A (cs)
CA (1)	CA2434743A1 (cs)
CZ (1)	CZ20031912A3 (cs)
EE (1)	EE200300322A (cs)
HR (1)	HRP20030559A2 (cs)
HU (1)	HUP0302741A3 (cs)
IL (1)	IL156933A0 (cs)
MA (1)	MA26266A1 (cs)
MX (1)	MXPA03006307A (cs)
MY (1)	MY136633A (cs)
NO (1)	NO20033206L (cs)
PE (1)	PE20020818A1 (cs)
PL (1)	PL365741A1 (cs)
RU (1)	RU2280453C2 (cs)
SK (1)	SK8992003A3 (cs)
TN (1)	TNSN03036A1 (cs)
UA (1)	UA80673C2 (cs)
WO (1)	WO2002056913A2 (cs)
YU (1)	YU57103A (cs)
ZA (1)	ZA200305437B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005046769A1 (de) *	2005-09-29	2007-04-05	Berlin-Chemie Ag	Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
FR2936706B1 (fr) *	2008-10-08	2010-12-17	Oreal	Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
US20110305758A1 (en) *	2009-01-29	2011-12-15	Mitsuhiro Matono	Orally disintegrating tablet having inner core
US10603285B2 (en) *	2015-03-19	2020-03-31	Daiichi Sankyo Company, Limited	Solid preparation including colorant
CN104988791A (zh) *	2015-06-25	2015-10-21	广东义晟实业有限公司	一种抗病毒添加剂及添加该添加剂的胶水和uv漆

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0072137A1 (en) *	1981-08-01	1983-02-16	Beecham Group Plc	Antiviral deoxyuridine compounds
HU196038B (en) *	1987-08-07	1988-09-28	Mta Koezponti Kemiai Kutato In	Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
DE4122337A1 (de) *	1991-07-05	1993-01-14	Cedona Pharm Bv	Pharmazeutische zubereitung
FR2737118B1 (fr) *	1995-07-28	1997-09-05	Oreal	Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
GB9521454D0 (en) *	1995-10-19	1995-12-20	Kappa Pharmaceuticals Ltd	Compositions for the treatment of conditions caused by herpes virus
US6558710B1 (en) *	1999-06-14	2003-05-06	Helen Rebecca Godfrey	Topical zinc compositions and methods of use
DE10162593A1 (de) *	2001-12-19	2003-07-03	Menarini Ricerche Spa	Stabilisierte topische Brivudin-Formulierungen

2001
- 2001-12-24 MY MYPI20015863A patent/MY136633A/en unknown
2002
- 2002-01-10 EE EEP200300322A patent/EE200300322A/xx unknown
- 2002-01-10 AU AU2002244642A patent/AU2002244642B2/en not_active Ceased
- 2002-01-10 CN CNB028037448A patent/CN1236777C/zh not_active Expired - Fee Related
- 2002-01-10 YU YU57103A patent/YU57103A/sh unknown
- 2002-01-10 WO PCT/EP2002/000163 patent/WO2002056913A2/en not_active Ceased
- 2002-01-10 US US10/466,305 patent/US20040087602A1/en not_active Abandoned
- 2002-01-10 PL PL02365741A patent/PL365741A1/xx not_active Application Discontinuation
- 2002-01-10 BR BR0206478-2A patent/BR0206478A/pt not_active IP Right Cessation
- 2002-01-10 IL IL15693302A patent/IL156933A0/xx unknown
- 2002-01-10 HR HR20030559A patent/HRP20030559A2/hr not_active Application Discontinuation
- 2002-01-10 JP JP2002557420A patent/JP2004519460A/ja active Pending
- 2002-01-10 SK SK899-2003A patent/SK8992003A3/sk not_active Application Discontinuation
- 2002-01-10 RU RU2003121639/15A patent/RU2280453C2/ru not_active IP Right Cessation
- 2002-01-10 EP EP02712810A patent/EP1365772A2/en not_active Withdrawn
- 2002-01-10 HU HU0302741A patent/HUP0302741A3/hu unknown
- 2002-01-10 CA CA002434743A patent/CA2434743A1/en not_active Abandoned
- 2002-01-10 CZ CZ20031912A patent/CZ20031912A3/cs unknown
- 2002-01-10 KR KR10-2003-7009444A patent/KR20030070109A/ko not_active Ceased
- 2002-01-10 MX MXPA03006307A patent/MXPA03006307A/es not_active Application Discontinuation
- 2002-01-16 AR ARP020100151A patent/AR035530A1/es not_active Application Discontinuation
- 2002-01-16 PE PE2002000027A patent/PE20020818A1/es not_active Application Discontinuation
- 2002-10-01 UA UA2003076388A patent/UA80673C2/uk unknown
2003
- 2003-06-30 MA MA27219A patent/MA26266A1/fr unknown
- 2003-07-08 TN TNPCT/EP2002/000163A patent/TNSN03036A1/fr unknown
- 2003-07-10 BG BG107988A patent/BG107988A/bg unknown
- 2003-07-15 NO NO20033206A patent/NO20033206L/no not_active Application Discontinuation
- 2003-07-15 ZA ZA200305437A patent/ZA200305437B/xx unknown

Also Published As

Publication number	Publication date
MY136633A (en)	2008-11-28
BG107988A (bg)	2004-09-30
NO20033206D0 (no)	2003-07-15
US20040087602A1 (en)	2004-05-06
MA26266A1 (fr)	2004-09-01
YU57103A (sh)	2006-08-17
KR20030070109A (ko)	2003-08-27
PL365741A1 (en)	2005-01-10
TNSN03036A1 (en)	2005-04-08
HUP0302741A2 (hu)	2003-11-28
CN1236777C (zh)	2006-01-18
CN1486185A (zh)	2004-03-31
AU2002244642B2 (en)	2005-12-15
EE200300322A (et)	2003-10-15
RU2003121639A (ru)	2005-02-10
HRP20030559A2 (en)	2005-06-30
BR0206478A (pt)	2003-12-30
HUP0302741A3 (en)	2007-06-28
AR035530A1 (es)	2004-06-02
MXPA03006307A (es)	2003-09-16
PE20020818A1 (es)	2002-10-21
ZA200305437B (en)	2004-07-15
SK8992003A3 (en)	2003-11-04
CA2434743A1 (en)	2002-07-25
JP2004519460A (ja)	2004-07-02
UA80673C2 (en)	2007-10-25
RU2280453C2 (ru)	2006-07-27
EP1365772A2 (en)	2003-12-03
NO20033206L (no)	2003-07-15
CZ20031912A3 (cs)	2004-01-14
WO2002056913A3 (en)	2002-11-07
WO2002056913A2 (en)	2002-07-25

Publication	Publication Date	Title
GB0108082D0 (en)	2001-05-23	Topical composition
EP1426027A4 (en)	2006-09-05	COMPOSITION AND COSMETIC PREPARATION CONTAINING THE SAID COMPOSITION
AU8015600A (en)	2001-04-23	Respiratory nitric oxide meter
EP1429829A4 (en)	2010-02-03	NITROGEN OXIDE GENERATION
AUPR113700A0 (en)	2000-11-23	Transition metal oxide compositions
EP1334724A4 (en)	2007-05-02	COMPOSITIONS FOR TOPICAL PREPARATIONS
GB0109143D0 (en)	2001-05-30	Antiperspirant compositions comprising microemulsions
PL369581A1 (en)	2005-05-02	Stabilized brivudine topical formulations
AU2001267707A1 (en)	2002-02-18	Antiperspirant formulations
GB0106601D0 (en)	2001-05-09	Antiperspirant formulations
GB0016937D0 (en)	2000-08-30	Antiperspirant compositions
GB0116945D0 (en)	2001-09-05	Antiperspirant formulations
GB0116946D0 (en)	2001-09-05	Antiperspirant formulations
EP1370240A4 (en)	2004-09-22	NEUROPROTECTOR FORMULATIONS AND METHOD
HUP0302741A3 (en)	2007-06-28	Stabilized brivudine topical formulations containing metal oxide pigments
AU2001267693A1 (en)	2002-02-18	Antiperspirant formulations
GB0108886D0 (en)	2001-05-30	Conductor composition II
AU2001241966A1 (en)	2001-10-15	Personal virtual assistant
AU2452302A (en)	2002-02-05	Sunscreen formulations containing nucleic acids
GB0110681D0 (en)	2001-06-20	Antiperspirant formulations
PL363921A1 (en)	2004-11-29	Skin moisturizing composition
HK1060299A (en)	2004-08-06	Stabilized brivudine topical formulations containing metal oxide pigments
GB0108888D0 (en)	2001-05-30	Conductor composition IV
AU2002358649A1 (en)	2003-06-30	Antiperspirant composition
GB0114746D0 (en)	2001-08-08	Medicinal composition